Aesculap to Distribute Misonix BoneScalpel
An example of the precision afforded by Misonix ultrasound cutting technologies: an eggshell is cut and the membrane is left intact. In an agreement finalized […]
news2
Revenue Guidance Revised as ATS Medical Seeks to Placate the FDA
Last week, word came from the FDA that ATS Medical would need to provide additional information and clarification to support its PMA for the ATS […]
Blue Shield of California Sees the 308-nanometer Light
Blue Shield of California, a plan that covers more than three million people, has approved payment for mild to moderate psoriasis treatment using the PhotoMedex […]
BioSphere to Market Microspheres in China
Company eyes large opportunity in treating liver cancer Rockland, MA-based BioSphere Medical reported this week that the Medical Device Department of the People’s Republic of […]
[Video Profile] Interview with John Seaberg, CEO of NeoChord
This interview with John Seaberg, CEO of NeoChord, is the first of many filmed earlier this month at the OMP Finance Forum. NeoChord aims to […]
Breast Cancer Screening Co-Pay Could Hurt Insurers’ Bottom Line
A new study in The New England Journal of Medicine found that a modest insurance co-pay was enough to deter many older women from getting […]
Luminex to Streamline Tyson’s Food Safety Network
As Tyson Food’s Richard Bond led an initiative to cut costs and improve earnings, he no doubt eyed the costly but necessary food safety and […]
Nanomaterial Coatings Help Drugs Bypass Bodily Defenses
A new study published in the January issue of ACS Nano offers insight into cutting edge world of drug delivery research. In the study, UCLA […]
FDA Puts Brakes on Expanded Indication for PreMD’s Skin Sterol Diagnostic
Company to decrease spending to ensure its ability to execute. Tortono, Ontario-based PreMD received a non-substantially equivalent letter from the FDA regarding its 510(k) submission […]
Private Equity Firm Warburg Pincus to Acquire Lifecore Biomedical
Even as access to cheap debt has dried up and the rate of deals flow has dwindled, Warburg Pincus seems to show no sign of […]